Aesthetic Medical International Holdings Group Limited (PAIYY)
OTCMKTS · Delayed Price · Currency is USD
0.1301
-0.0199 (-13.27%)
At close: Dec 11, 2025
PAIYY Revenue
Aesthetic Medical International Holdings Group had revenue of 350.61M CNY in the half year ending June 30, 2025, with 9.80% growth. This brings the company's revenue in the last twelve months to 742.89M, up 2.23% year-over-year. In the year 2024, Aesthetic Medical International Holdings Group had annual revenue of 755.67M with 10.71% growth.
Revenue (ttm)
742.89M CNY
Revenue Growth
+2.23%
P/S Ratio
0.06
Revenue / Employee
567.53K CNY
Employees
1,309
Market Cap
6.33M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 755.67M | 73.08M | 10.71% |
| Dec 31, 2023 | 682.59M | 12.50M | 1.86% |
| Dec 31, 2022 | 670.09M | 24.50M | 3.79% |
| Dec 31, 2021 | 645.59M | -255.98M | -28.39% |
| Dec 31, 2020 | 901.57M | 32.52M | 3.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |